On January 15 th , 2025, Monte Nido Vice President of Medical Services, Joel Jahraus MD, CEDS, FED, FIAEDP hosted The GLP-1 Dilemma: Exploring the Intersection of Weight Loss Success and Eating Disorder Risks, an informative webinar discussing a topic that is at the forefront of many conversations in the healthcare field
Technology Integration for Program Efficiency Digital tools can greatly enhance program effectiveness
Clinical data in human beings are inadequate to establish safety in early pregnancy
retatrutide research uk Serious Adverse Events (SAEs) Across available datasets, the overall serious adverse event profile has remained consistent with incretin-class expectations
Repeated freeze-thaw cycles are not recommended because they may reduce material quality
#PharmaManufacturing #DrugDevelopment #Formulation #Pharmaceuticals #CapsuleSize To view or add a comment, sign in Innovation in GLP-1 Therapy: The Future of Semaglutide Nasal Spray The global race to redefine GLP-1based therapies is acceleratingand Semaglutide Nasal Spray represents a bold step forward in patient-centric innovation